155 related articles for article (PubMed ID: 7587043)
1. Switch therapy in community-acquired pneumonia.
Ramirez JA
Diagn Microbiol Infect Dis; 1995; 22(1-2):219-23. PubMed ID: 7587043
[TBL] [Abstract][Full Text] [Related]
2. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy.
Rhew DC; Hackner D; Henderson L; Ellrodt AG; Weingarten SR
Chest; 1998 Jan; 113(1):142-6. PubMed ID: 9440581
[TBL] [Abstract][Full Text] [Related]
3. Managing antiinfective therapy of community-acquired pneumonia in the hospital setting: focus on switch therapy.
Ramirez JA
Pharmacotherapy; 2001 Jul; 21(7 Pt 2):79S-82S. PubMed ID: 11446522
[TBL] [Abstract][Full Text] [Related]
4. The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias.
Cunha BA
Med Clin North Am; 1995 May; 79(3):581-97. PubMed ID: 7752730
[TBL] [Abstract][Full Text] [Related]
5. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
[TBL] [Abstract][Full Text] [Related]
7. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.
Ramirez JA; Vargas S; Ritter GW; Brier ME; Wright A; Smith S; Newman D; Burke J; Mushtaq M; Huang A
Arch Intern Med; 1999 Nov; 159(20):2449-54. PubMed ID: 10665893
[TBL] [Abstract][Full Text] [Related]
8. Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
Kuti JL; Capitano B; Nicolau DP
Pharmacoeconomics; 2002; 20(8):513-28. PubMed ID: 12109917
[TBL] [Abstract][Full Text] [Related]
9. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.
Siegel RE
Clin Chest Med; 1999 Sep; 20(3):599-605. PubMed ID: 10516907
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
[TBL] [Abstract][Full Text] [Related]
11. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia.
Ramirez JA; Bordon J
Arch Intern Med; 2001 Mar; 161(6):848-50. PubMed ID: 11268227
[TBL] [Abstract][Full Text] [Related]
12. [Switch therapy for community acquired pneumonia].
Aoshima M
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():326-30. PubMed ID: 17455640
[No Abstract] [Full Text] [Related]
13. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
Brixner DI
Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
[No Abstract] [Full Text] [Related]
14. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
[TBL] [Abstract][Full Text] [Related]
15. Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia.
Ramirez JA
Ann Pharmacother; 1998 Jan; 32(1):S22-6. PubMed ID: 9475836
[TBL] [Abstract][Full Text] [Related]
16. Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.
Ramirez JA; Cooper AC; Wiemken T; Gardiner D; Babinchak T;
BMC Infect Dis; 2012 Jul; 12():159. PubMed ID: 22812672
[TBL] [Abstract][Full Text] [Related]
17. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
[TBL] [Abstract][Full Text] [Related]
18. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.
Rhew DC; Tu GS; Ofman J; Henning JM; Richards MS; Weingarten SR
Arch Intern Med; 2001 Mar; 161(5):722-7. PubMed ID: 11231705
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacoeconomic estimation of cost of community acquired pneumonia therapy].
Kulidzhanov AIu; Sirotko II; Koriakin PM; Korchazhkin VS
Voen Med Zh; 2001 Jan; 322(1):50-2. PubMed ID: 11219929
[No Abstract] [Full Text] [Related]
20. Antibiotic streamlining: development and justification of an antibiotic streamlining program.
Ramirez JA
Pharm Pract Manag Q; 1996 Oct; 16(3):19-34. PubMed ID: 10166232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
